About Sexually Transmitted Diseases Testing
STDs, also known as STIs, are infectious diseases caused by bacteria, yeast, parasites, and viruses, and are transmitted through sexual contact, thus generating the need for STD testing and demand for devices used for testing.
Technavio’s analysts forecast the global sexually transmitted diseases testing market to grow at a CAGR of 8.61% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global sexually transmitted diseases testing market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Sexually Transmitted Diseases Testing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Abbott
• bioMerieux
• Bio-Rad Laboratories
• F. Hoffmann La Roche
Market driver
• Rise in STDs
• For a full, detailed list, view our report
Market challenge
• Lack of trained professionals
• For a full, detailed list, view our report
Market trend
• High demand for POC testing
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Global STD testing market overview
• Market sizing 2017
• Global STD testing market
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY TESTING DEVICES
• Global STD testing market by testing devices
• Comparison by testing devices
• Global STD testing market by laboratory testing devices
• Global STD testing market by POC testing devices
• Market opportunity by testing devices
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• STD testing market in Americas
• STD testing market in EMEA
• STD testing market in APAC
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• High demand for POC testing
• Rising awareness regarding HIV
• Increasing importance of promotional activities
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• bioMerieux
• Bio-Rad Laboratories
• F. Hoffmann La Roche
• Other prominent vendors
• Company
• Description
PART 15: APPENDIX
• List of abbreviations
List of Exhibits
Exhibit 01: Related market
Exhibit 02: Market characteristics
Exhibit 03: Market segments
Exhibit 04: Market definition: Inclusions and exclusions checklist
Exhibit 05: Validation techniques employed for market sizing 2017
Exhibit 06: Global STD testing market 2017-2022 ($ billions)
Exhibit 07: Global STD testing market: Year-over-year (YoY) growth 2018-2022 (%)
Exhibit 08: Five forces analysis 2017
Exhibit 09: Five forces analysis 2022
Exhibit 10: Bargaining power of buyers
Exhibit 11: Bargaining power of suppliers
Exhibit 12: Threat of new entrants
Exhibit 13: Threat of substitutes
Exhibit 14: Threat of rivalry
Exhibit 15: Market condition: Five forces 2017
Exhibit 16: Market condition: Five forces 2022
Exhibit 17: Global STD testing market by testing devices 2017-2022 (%)
Exhibit 18: Comparison by testing devices
Exhibit 19: Global STD testing market by laboratory testing devices 2017-2022 ($ billions)
Exhibit 20: Global STD testing market by laboratory testing devices: YoY growth 2018-2022 (%)
Exhibit 21: Global STD testing market by POC testing devices 2017-2022 ($ billions)
Exhibit 22: Global STD testing market by POC testing devices: YoY growth 2018-2022 (%)
Exhibit 23: Market opportunity by testing devices
Exhibit 24: Customer landscape
Exhibit 25: Global STD testing market by geography 2017-2022 (%)
Exhibit 26: Regional comparison
Exhibit 27: STD testing market in Americas 2017-2022 ($ billions)
Exhibit 28: Americas: YoY growth 2018-2022 (%)
Exhibit 29: Top three countries in Americas
Exhibit 30: STD testing market in EMEA 2017-2022 ($ billions)
Exhibit 31: STD testing market in EMEA: YoY growth 2018-2022 (%)
Exhibit 32: Top three countries in EMEA
Exhibit 33: STD testing market in APAC 2017-2022 ($ billions)
Exhibit 34: STD testing market in APAC: YoY growth 2018-2022 (%)
Exhibit 35: Top three countries in APAC
Exhibit 36: Market opportunity
Exhibit 37: Vendor landscape
Exhibit 38: Landscape disruption
Exhibit 39: Vendors covered
Exhibit 40: Vendor classification
Exhibit 41: Market positioning of vendors
Exhibit 42: Vendor overview
Exhibit 43: Abbott: Business segments
Exhibit 44: Abbott: Organizational developments
Exhibit 45: Abbott: Geographic focus
Exhibit 46: Abbott: Segment focus
Exhibit 47: Abbott: Key offerings
Exhibit 48: Vendor overview
Exhibit 49: bioMerieux: Business segments
Exhibit 50: bioMerieux: Organizational developments
Exhibit 51: bioMerieux: Geographic focus
Exhibit 52: bioMerieux: Segment focus
Exhibit 53: bioMerieux: Key offerings
Exhibit 54: Vendor overview
Exhibit 55: Bio-Rad laboratories: Business segments
Exhibit 56: Bio-Rad laboratories: Organizational developments
Exhibit 57: Bio-Rad Laboratories: Geographic focus
Exhibit 58: Bio-Rad Laboratories: Segment focus
Exhibit 59: Bio-Rad laboratories: Key offerings
Exhibit 60: Vendor overview
Exhibit 61: F. Hoffmann La Roche: Business segments
Exhibit 62: F. Hoffmann La Roche: Organizational developments
Exhibit 63: F. Hoffmann La Roche: Geographic focus
Exhibit 64: F. Hoffmann La Roche: Segment focus
Exhibit 65: F. Hoffmann La Roche: Key offerings
